EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Therapeutic potential of thymoquinone in regulating p63, claudin, and periostin in chronic rhinosinusitis with nasal polyps: An animal model study

Loriana Ulfa, Delfitri Munir, Andrina Ym Rambe, Farhat Farhat, Retno S Wardani, Mustafa M Amin, Devira Zahara, Dedi Ardinata

Narra J · 2025

DOI: 10.52225/narra.v5i1.1728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Narra J, 2025. Verfasst von Loriana Ulfa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Philosophy Doctor in Medicine Program, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia. Hauptthemen laut MEDLINE: Sinusitis, Benzoquinones, Cell Adhesion Molecules, Nasal Polyps. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High recurrence rate and the necessity for repeated surgical interventions contribute to the chronicity and treatment-resistant nature of chronic rhinosinusitis with nasal polyps (CRSwNP). Thymoquinone, known for its protective effects on epithelial integrity, has not been previously explored in CRSwNP. The aim of this study was to investigate the therapeutic potential of thymoquinone to restore epithelial integrity by assessing p63 transcription factor and claudin protein expressions, as well as periostin mRNA expression in an animal model. An in vivo study using post-test-only control group design was conducted in which male Wistar rats were randomly assigned to three groups, each consisting of 10 animals: healthy group, CRSwNP group, and thymoquinone-treated group for three weeks. Immunohistochemistry was used to analyze the p63 and claudin protein expressions, while periostin mRNA expression was quantified using quantitative reverse transcription polymerase chain reaction (qRT-PCR). This study found that thymoquinone significantly reduced p63 transcription factor expression compared to the untreated CRSwNP group (p=0.009). Claudin protein expression was significantly higher in thymoquinone-treated group compared to CRSwNP group (p=0.007), indicating improved epithelial barrier function. Periostin mRNA expression showed no significant difference between healthy and thymoquinone-treated groups (p=0.564), but a significant decrease was observed in CRSwNP group compared to thymoquinone-treated group (p=0.000) and between the healthy and CRSwNP groups (p=0.002), suggesting attenuation of tissue remodeling and inflammation. In conclusion, thymoquinone could enhance sinonasal epithelial barrier integrity in CRSwNP by downregulating p63 transcription factor, upregulating claudin protein expression, and reducing periostin mRNA expression. These findings emphasize the potential of thymoquinone as a therapeutic agent to mitigate inflammation and tissue remodeling in CRSwNP, warranting further investigation as a novel treatment option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisBenzoquinonesCell Adhesion MoleculesNasal PolypsRhinitisClaudinsAnimalsRats, WistarMaleRatsChronic DiseaseDisease Models, AnimalRhinosinusitisPeriostin

Stichwörter der Autor:innen

CRSwNPclaudinp63 transcription factorperiostinthymoquinone

Substanzen

thymoquinoneBenzoquinonesCell Adhesion MoleculesClaudinsPostn protein, ratPeriostin

Autor:innen und Institutionen

  • Philosophy Doctor in Medicine Program, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Ear, Nose, and Throat, Faculty of Medicine, Universitas Riau, Pekanbaru, Indonesia.
  • Department of Ear, Nose, and Throat, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
  • Department of Ear, Nose, and Throat, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • Department of Ear, Nose, and Throat, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Department of Psychiatry, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.

Zitieren

APA

Ulfa, L., Munir, D., Rambe, A. Y., Farhat, F., Wardani, R. S., Amin, M. M., Zahara, D., & Ardinata, D. (2025). Therapeutic potential of thymoquinone in regulating p63, claudin, and periostin in chronic rhinosinusitis with nasal polyps: An animal model study. Narra J. https://doi.org/10.52225/narra.v5i1.1728

Vancouver

Ulfa L, Munir D, Rambe AY, Farhat F, Wardani RS, Amin MM, et al. Therapeutic potential of thymoquinone in regulating p63, claudin, and periostin in chronic rhinosinusitis with nasal polyps: An animal model study. Narra J. 2025. doi:10.52225/narra.v5i1.1728

BibTeX
@article{Ulfa2025,
  author = {Ulfa, Loriana and Munir, Delfitri and Rambe, Andrina Ym and Farhat, Farhat and Wardani, Retno S and Amin, Mustafa M and Zahara, Devira and Ardinata, Dedi},
  title = {Therapeutic potential of thymoquinone in regulating p63, claudin, and periostin in chronic rhinosinusitis with nasal polyps: An animal model study},
  journal = {Narra J},
  year = {2025},
  doi = {10.52225/narra.v5i1.1728}
}
Kostenlos starten →